30
www.corerxpharma.com

Core rx presentation_2012

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Core rx presentation_2012

www.corerxpharma.com

Page 2: Core rx presentation_2012

CoreRx, Inc OverviewOur Core Business

CoreRx, Inc. is a Dosage Form Development company specializing in formulation development, analytical development and clinical manufacturing of various dosage forms

• Drug Characterization

• Preformulation

• Formulation Development • Analytical Development

• Clinical Trial Materials Manufacturing

Page 3: Core rx presentation_2012

Our Core Focus

• Complete client satisfaction

• Highest quality science

• Consistent and effective communications

• Strong timeline management

• Full attention to client goals at all levels

Page 4: Core rx presentation_2012

Why CoreRx?

• People and ExpertiseIt all boils down to people and trust..

• CommunicationEffective, Scientist-to-Scientist communication is the cornerstone to every CoreRx™ project’s success.

• FlexibilityCoreRx™ scientists, management, and systems ensure flexibility and agility, allowing for direction changes without inflexible systems and bureaucratic hassles.

Page 5: Core rx presentation_2012

Why CoreRx?• Speed

CoreRx™ understands that developing innovative solutions for improved patient care, combined with the bottom line, revenues and profitability, are tied to getting your product on the market as quickly as possible.

• EducationAffiliation with Univ. of South Florida as Center for Advanced Pharmaceutical Learning. Students will learn hands-on techniques in industrial pharmaceutics from member of CoreRx team who are Associate Faculty at USF.

• Quality systemsDocumentation, quality, and operational systems are a necessity in a GLP/cGMP environment. Quality & timeliness must go hand in hand.

Page 6: Core rx presentation_2012

Why CoreRx…?

• Oh yes… and Location

Page 7: Core rx presentation_2012

Executive/Scientific Team

• Todd R. Daviau, Ph.D. - Chief Executive Officer– 25+ years of pharmaceutical experience – Director of the Analytical Group for MDS Pharma Services– Guilford Pharmaceuticals (GliadelTM)– Nova (later Scios) Pharmaceuticals

• Brian McMillan, Vice President, Formulation Development– 20+ years of experience in pharmaceutical formulation development– MDS Pharma Services– Bausch and Lomb Pharmaceuticals– Roxane Laboratories

Page 8: Core rx presentation_2012

Executive/Scientific Team

• Mark J. Licarde, Vice President, Technical Operations– 28+ years in pharmaceutical manufacturing – MDS Pharma Services – Mylan Pharmaceuticals– Bristol Myers Squibb

• Jim Davis, M.S., Vice President, Business Operations– 16+ years of pharmaceutical experience– MDS Pharma Services– Bausch and Lomb– Proceutics / Oread

Page 9: Core rx presentation_2012

History

• Founded in 2006

• Started with 5 employees

• Now at 41 employees

• Grown from 3300 sq. ft. to over 35,000 sq ft.

Page 10: Core rx presentation_2012

CoreRx’s Convenient Location

Clearwater, Florida~15 minutes to Tampa Airport (TPA)

cGMP Compliant

FDA/FL DOH Registered

DEA LicensedSchedule II - V

Insert new map

Page 11: Core rx presentation_2012

CoreRx Facility Overview

• Approximately 35,000 square feet• 19 Manufacturing suites13 cGMP – including 1 for special projects (low RH, low light, etc.)6 Non-GMP – formulation development • Manufacturing capacity – up to ~500kg• Expanded laboratory space:•Formulation Development•cGMP Manufacturing•Stability storage testing•Analytical

•R&D•cGMP

 

Page 12: Core rx presentation_2012

New LocationFormulation Suites

Analytical Labs

Warehouse

cGMP ManufacturingArea

Admin areas

Page 13: Core rx presentation_2012

Core Competenciesby Business Unit

• Preformulation Services– Drug substance characterization

• Analytical Services– Method Development and Validation

• Formulation Development– Liquids, Semi-solids and Solids

• Manufacturing, Packaging & Labeling– API in Capsule or in Bottle– Liquids, Semi-solids and Solids– Matching Placebo manufacture– Blinding of reference product (over-encapsulation)

• Stability Program Management– ICH or customized stability parameters

Page 14: Core rx presentation_2012

Additional Capabilities

• CoreRx is committed to adding innovation where we see a client need– API in capsule/bottle services

• Xcelodose ®• Quantos®

– Multi-layer tablet (up to 3 layers)• FlexiTab ®

– Liquid in capsule services– Multi-particulate capsules

• CoreRx licensed with DEA– Controlled substances (II – V)

• Overencapsulation services – comparator or “blinding” studies

Page 15: Core rx presentation_2012

Project Management/Logistics

• Project Manager is assigned to manage:– Project planning and Execution– Team leadership with integration of technical– Manage all CoreRx-Client communications

• Project Teams are made up of subject matter experts which represent their respective disciplines:– Project Management/Logistics– Analytical Chemistry– Formulation Development– Manufacturing– Quality Assurance

Page 16: Core rx presentation_2012

SERVICES

Page 17: Core rx presentation_2012

Preformulation

Page 18: Core rx presentation_2012

Preformulation CharacterizationSolid and/or Solution Characterization can be Conducted Utilizing the Following

Instrumentation/Procedures:• Thermal evaluation

• DSC, TGA, Hot-stage microscope• FTIR• X-ray Diffraction• Particle size/morphology• Polarized microscopy• Moisture content

• KF, moisture analyzer• Moisture sorption profile• pH solubility • Partition coefficient• Photostability• Intrinsic dissolution

Page 19: Core rx presentation_2012

Analytical Services

Experienced Professionals in Analytical Chemistry• Method Development, Qualification and Validation

• HPLC, uPLC, Dissolution, etc.

• Raw Material Testing (select)• Stability Sample Analysis• Dissolution Testing• Chiral Analysis• Cleaning Analysis/Verification• CMC Technical Packages

Page 20: Core rx presentation_2012

Analytical Services

• Analytical Support for Formulation Development• Stability and QC Release Testing• API/Reference Standard Characterization• Isolation and Identification of Impurities• Physical Chemistry

Page 21: Core rx presentation_2012

Formulation Services

• Solids• Tablets, Capsules, Modified Release, Coatings

• Semi-Solids• Creams, Gels, Ointments, lotions, etc.

• Dispersed Systems• Emulsions & Suspensions

• Liquids• Oral, Ophthalmic, Parenteral

Page 22: Core rx presentation_2012

Formulation Services

Solid Oral Capabilities• API in Bottle/Capsule• Excipient Compatibility• Oral Drug Delivery

• Tablets, Capsules, Powders, Pellets, Mini-Tablets• Solutions, Suspensions, Emulsions, Powders for Reconstitution

• Solid Dispersions• Lipid Formulation Delivery for Poorly Soluble/Bioavailable APIs• Multi-Phasic, Extended and/or Delayed Release Drug Delivery• Highly Potent Compounds

Page 23: Core rx presentation_2012

Contract Manufacturing Services

• Manufacturing– API in Capsule/Bottles– Tablets, Capsules, Pellets, Mini-Tablets– Liquid in Capsule

• Solutions, Suspensions, Emulsions

• Over-Encapsulation, Reference Product Blinding • Packaging & Labeling

• Other Services– Matching Placebo Manufacturing– Technology Transfer

Page 24: Core rx presentation_2012

Stability• ICH Conditions

– 25oC/60%RH, 30oC/65%RH, 40oC/75%RH– Custom conditions also available

• Protocol design• Report generation• Stability software management system

– SLIM/SLIMStat

• Sample analysis• Secure storage

Page 25: Core rx presentation_2012

Why CoreRx…?

• Quality First Focus– Numerous audits reinforcing compliance

• Responsiveness– Flexible manufacturing model– Unique project management team structure with client-centric focus– Cross training program for employees

• Technology– Investment in new equipment and expertise as they become available

• Expertise– Ability to attract top-level talent with high-level benefits package

• Reliability– Leveraging our company’s size to your advantage

Page 26: Core rx presentation_2012

Faster to Clinic with Xcelodose ® or Quantos®

• Manufacturing– Advanced neat drug dosing directly into capsule or bottle– Decreases lab to clinic development– Decreases API requirements– Decrease risk of stability– Minimizes API waste

Page 27: Core rx presentation_2012

…and now even Faster to Clinic with ClinicFirstSM 60Day Guarantee

• The CoreRx ClinicFirst program is designed for clients requiring rapid supply of clinical trial materials for First-in-Man (Phase I) clinical studies.

• API in Capsule• Blend in Capsule• API in Bottle• Blend in Bottle

Page 28: Core rx presentation_2012

Introducing SuiteViewTM…

• Formulation & Manufacturing– Real-time video feed (Pan, Tilt & Zoom)– Remote/IP access

• Password controlled

– Two way communication• Reduce travel time/costs

Page 29: Core rx presentation_2012

Choose CoreRx

The projects we work on may change....

our values won't...

quality, reliability, value, integrity

Page 30: Core rx presentation_2012

www.corerxpharma.com